Development and characterization of dexamethasone nanodispersion for the effective treatment of diabetic retinopathy

IF 16.4 1区化学 Q1 CHEMISTRY, MULTIDISCIPLINARY

Accounts of Chemical Research Pub Date : 2024-05-25 DOI:10.1080/24701556.2024.2355366

Venkateshwaran Krishnaswami, Balakrishnan Natarajan, S. Uma Maheswari, Mukunthan Veerababu, Krishnaveni Nambiraj, Sindha Madhar Mydeen Mohammed

引用次数: 0

Abstract

Diabetic retinopathy is the most common complication of diabetes and remains the leading cause of vision loss worldwide. The potent glucocorticoid based anti-inflammatory drug dexamethasone (DEX) c...

查看原文本刊更多论文

用于有效治疗糖尿病视网膜病变的地塞米松纳米分散体的开发与表征

糖尿病视网膜病变是糖尿病最常见的并发症，也是全球视力丧失的主要原因。以糖皮质激素为基础的强效抗炎药地塞米松（DEX）可以减轻糖尿病视网膜病变的症状。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Accounts of Chemical Research 化学-化学综合

CiteScore

31.40

自引率

1.10%

发文量

312

审稿时长

2 months

期刊介绍： Accounts of Chemical Research presents short, concise and critical articles offering easy-to-read overviews of basic research and applications in all areas of chemistry and biochemistry. These short reviews focus on research from the author’s own laboratory and are designed to teach the reader about a research project. In addition, Accounts of Chemical Research publishes commentaries that give an informed opinion on a current research problem. Special Issues online are devoted to a single topic of unusual activity and significance. Accounts of Chemical Research replaces the traditional article abstract with an article "Conspectus." These entries synopsize the research affording the reader a closer look at the content and significance of an article. Through this provision of a more detailed description of the article contents, the Conspectus enhances the article's discoverability by search engines and the exposure for the research.